Preventing Heroin Relapse: Cannabidiol

ID Number BI-087-14

Principal Investigator(s)
Yasmin Hurd

Department(s) or Division(s)

Research Entity
Addiction Institute at Mount Sinai


Heroin dependence is a chronic, relapsing medical disorder characterized by persistent drug craving, with loss of control and profound drug seeking behavior. Traditional opioid abuse treatments such as methadone have targeted opioid receptors since heroin metabolites bind with highest affinity to these receptors. However, a large proportion of patients under these medications still relapse in heroin use.

Our clinical trial investigates the efficacy of a research medication Cannabidiol that indirectly targets non-opioid neuronal receptors. Phase I studies in human showed that Cannabidiol was safe with only minor side effects. We are now recruiting research volunteers to participate in Phase II of this very important and much needed clinical research.

Contact Information
Sharron Spriggs
(212) 420-4275

Recruiting Patients: No